ESR1 and breast carcinoma: The enhanced viability and proliferative responses of ER+ vs. ER- breast cancer cells during short-term co-culture with human bone tissue fragments and conditioned media are consistent with long-established clinical patterns demonstrating a propensity for ER+ breast cancer to preferentially target the skeleton during metastatic spread [20–23].